Russia Buys 80% Of Iran's Major MS Drug, But Iran Eyes More
This article was originally published in PharmAsia News
Executive Summary
Russia is serving as a friendly market for Iran's multiple sclerosis drugs, currently importing $20 million worth, but targeted for $100 million in the years ahead, according to Health Minister Hassan Qazizadeh Hashemi.